200 related articles for article (PubMed ID: 28610791)
1. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.
Bax HI; Bakker-Woudenberg IAJM; de Vogel CP; van der Meijden A; Verbon A; de Steenwinkel JEM
Tuberculosis (Edinb); 2017 Jul; 105():80-85. PubMed ID: 28610791
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
3. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
[TBL] [Abstract][Full Text] [Related]
4. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
[TBL] [Abstract][Full Text] [Related]
5. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
[TBL] [Abstract][Full Text] [Related]
6. Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
Bax HI; de Steenwinkel JE; Ten Kate MT; van der Meijden A; Verbon A; Bakker-Woudenberg IA
J Antimicrob Chemother; 2015 Oct; 70(10):2828-37. PubMed ID: 26183185
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay.
Marcel N; Nahta A; Balganesh M
Chemotherapy; 2008; 54(5):404-11. PubMed ID: 18772589
[TBL] [Abstract][Full Text] [Related]
8. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
[TBL] [Abstract][Full Text] [Related]
9. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
[TBL] [Abstract][Full Text] [Related]
12. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
[TBL] [Abstract][Full Text] [Related]
14. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
Trakada G; Tsiamita M; Spiropoulos K
Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
[TBL] [Abstract][Full Text] [Related]
16. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using
Genestet C; Ader F; Pichat C; Lina G; Dumitrescu O; Goutelle S
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061753
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
Kasule GW; Kateete DP; Joloba ML
BMC Infect Dis; 2016 Apr; 16():173. PubMed ID: 27097724
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis.
Martin A; Montoro E; Lemus D; Simboli N; Morcillo N; Velasco M; Chauca J; Barrera L; Ritacco V; Portaels F; Palomino JC
J Microbiol Methods; 2005 Nov; 63(2):145-50. PubMed ID: 15893391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
